4th nuAnal
International
Oncology Forum Program At glance
Forum Day One, Saturday 19 April 2025
Improving Survival Outcomes in HR+HER2 Negative Early Breast Cancer
Systemic Therapy for Small HER2 Positive Tumors.
Latest Updates in Radiotherapy Fractionation for EBC.
Navigating the Treatment landscape for HR+ HER2- Node Positive High Risk Early Breast Cancer Patients
Breaking new grounds in HR+ HER2- Early Breast Cancer
Q&A Session, Panel Discussion.
Metastatic Triple Negative Breast Cancer Patients: Perspectives and Strategies..
Enhancing ADC Utilization in HR+/HER2- MBC: A Guide to Optimal Treatment
Sequencing.
Case-based Panel Discussion- MBC with Brain Metastases.
Individualize HR+ Breast Cancer Management post CDK4/6 inhibitors.
Role of Sacituzumab Govetican in mTNBC Management.
Q&A Session, Panel Discussion.
Recent Updates in the Management of Uterine Cancers.
Evolving Landscape of Cervical Cancer Management.
Case-based Panel Discussion: Advanced Ovarian Cancer.
Advancing ADC Therapies in Platinum-Resistant Ovarian Cancer.
Dual targets: Optimizing advanced Endometrial Cancer Outcome.
Q&A Session, Panel Discussion.
Forum Day Two, Sunday 20 April 2025
Recent Updates in Management of Resectable NSCLC.
Latest Updates in the Management of Biomarker Driven Advanced NSCLC.
Case-based Discussion- Advanced Lung Cancer Case Discussion.
Treatment Evolution in the management of advanced EGFRm NSCLC.
Evolution of Checkpoint Blockade in rNSCLC.
Atezolizumab in ES-SCLC: Redefining the First-Line Standard of Care.
Q&A Session, Panel Discussion.
Current Approaches to Treatment of Advanced Clear Cell RCC.
Latest Updates Metastatic Bladder Cancer Management.
MCSPC to mCRPC: Navigating Treatment Advances and Sequencing
Q&A Session, Panel Discussion.
Challenging Cases in the Management of colorectal Cancers.
Progress in Management of Hepatocelluar Carcinoma
The Evolving Role of Systemic Therapies in Hepatobiliary and Pancreatic Cancer.
New Horizons in Management of Gastroesophageal Cancers
Q&A Session, Panel Discussion.
